nexiguran ziclumeran

Drug identity checked against registry records

Also recorded as NTLA-2001

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of NTLA-2001 in ATTRv-PNNCT06672237Intellia TherapeuticsPhase 3Active not recruiting2027-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.